Quantitative analysis of the expression of human n-myristoyltransferase 1 (hNMT-1) in cancers

Open Biomarkers Journal

Volumn 2, Issue 1, 2009, Pages 6-10

  Chen, Lifeng ^a   Ling, Binbing ^a   Alcorn, Jane ^a   Yang, Jian ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN N MYRISTOYLTRANSFERASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UPREGULATION;

EID: 67650152107     PISSN: None     EISSN: 18753183     Source Type: Journal    
DOI: 10.2174/1875318300902010006     Document Type: Article

References (36)

1. Luthra M, Balasubramanian D. Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J Biol Chem 1993; 268: 18119-27.
2. Hurley JH, Dean AM, Sohl JL, Koshland DE Jr, Stroud RM. Regulation of an enzyme by phosphorylation at the active site. Science 1990; 249: 1012-6.
3. David SSM, Haley BE. ATP nucleotidylation of creatine kinase. Biochemistry 1999; 38: 8492-500.
4. Parodi AJ. Protein glycosylation and its role in protein folding. Annu Rev Biochem 2000; 69: 69-93.
5. O'Shea JJ, Kanno Y, Chen X, Levy DE. Cell signaling. Stat acetylation-a key facet of cytokine signaling? Science 2005; 307: 217-8.
6. Resh MD. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 1994; 76: 411-3.
7. Boutin JA. Myristoylation. Cell Signal 1997; 9: 15-35.
8. Raju RV, Datla RS, Moyana TN, Kakkar R, Carlsen SA, Sharma RK. N-myristoyltransferase. Mol Cell Biochem 2000; 204: 135-55.
9. Raju RV, Magnuson BA, Sharma RK. Mammalian myristoyl CoA: protein N-myristoyltransferase. Mol Cell Biochem 1995; 149: 191-202.
10. Robbins SM, Quintrell NA, Bishop JM. Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 1995; 15: 3507-15.
11. Bhatnagar RS, Futterer K, Farazi TA, et al. Structure of N-myristoyltransferase with bound myristoyl-CoA and peptide substrate analogs. Nat Struct Biol 1998; 5: 1091-7.
12. Sogabe S, Masubuchi M, Sakata K, et al. Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors. Chem Biol 2002; 9: 1119-28.
13. Weston SA, Camble R, Colls J, et al. Crystal structure of the antifungal target N-myristoyl transferase. Nat Struct Biol 1998; 5: 213-21.
14. Bhatnagar RS, Jackson-Machelski E, McWherter CA, Gordon JI. Isothermal titration calorimetric studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem 1994: 269: 11045-53.
15. Duronio RJ, Reed SI, Gordon JI. Mutations of human myristoyl-CoA: protein N-myristoyltransferase cause temperature-sensitive myristic acid auxotrophy in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1992; 89: 4129-33.
16. Peseckis SM, Resh MD. Fatty acyl transfer by human N-myristyl transferase is dependent upon conserved cysteine and histidine residues. J Biol Chem 1994; 269: 30888-92.
17. Carr SA, Biemann K, Shoji S, Parmelee DC, Titani K. n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci USA 1982; 79: 6128-31.
18. Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000; 290: 1761-5.
19. Schultz AM, Henderson LE, Oroszlan S, Garber EA, Hanafusa H. Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science 1985; 227: 427-9.
20. Marchildon GA, Casnellie JE, Walsh KA, Krebs EG. Covalently bound myristate in a lymphoma tyrosine protein kinase. Proc Natl Acad Sci USA 1984; 81: 7679-82.
21. Nadler MJ, Harrison ML, Ashendel CL, Cassady JM, Geahlen RL. Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lck. Biochemistry 1993; 32: 9250-5.
22. 2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol 1997; 136: 1023-35.
23. Aitken A, Cohen P, Santikarn S, et al. Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett 1982; 150: 314-8.
24. Schultz AM, Tsai SC, Kung HF, Oroszlan S, Moss J, Vaughan M. Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. Biochem Biophys Res Commun 1987; 146: 1234-9.
25. Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci USA 1989; 86: 8655-9.
26. Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 1989; 86: 9549-53.
27. Marc D, Masson G, Girard M, van der Werf S. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol 1990; 64: 4099-107.
28. Gottlinger HG, Sodroski JG, Haseltine WA. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989; 86: 5781-5.
29. Shoji S, Kurosawa T, Inoue H, Funakoshi T, Kubota Y. Human cellular src gene product: identification of the myristoylated pp60c-src and blockage of its myristoyl acylation with N-fatty acyl compounds resulted in the suppression of colony formation. Biochem Biophys Res Commun 1990; 173: 894-901.
30. Magnuson BA, Raju RV, Moyana TN, Sharma RK. Increased N-myristoyltransferase activity observed in rat and human colonic tumors. J Natl Cancer Inst 1995; 87: 1630-5.
31. Rajala RV, Radhi JM, Kakkar R, Datla RS, Sharma RK. Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 2000; 88: 1992-9.
32. Lu Y, Selvakumar P, Ali K, et al. Expression of N-myristoyltransferase in human brain tumors. Neurochem Res 2005; 30: 9-13.
33. French KJ, Zhuang Y, Schrecengost RS, Copper JE, Xia Z, Smith CD. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1. J Pharmacol Exp Ther 2004; 309: 340-7.
34. Takemune N, Misumi S, Furuishi K, Shoji S. Blockage of HIV-1 production through inhibition of proviral DNA synthesis by N,O-didecanoyl serinal dimethylacetal. IUBMB Life 1999; 48: 311-5.
35. Takamune N, Hamada H, Misumi S, Shoji S. Novel strategy for anti-HIV-1 action: selective cytotoxic effect of N-myristoyltransferase inhibitor on HIV-1-infected cells. FEBS Lett 2002; 527: 138-42.
36. Dimmock JR, Jha A, Zello GA, et al. 3,5-bis(phenylmethylene)-1-(N-arylmaleamoyl)-4-piperidones: a novel group of cytotoxic agents. J Enzyme Inhib Med Chem 2003; 18: 325-32.